PMID: 16532655Mar 15, 2006Paper

Prophylaxis of pertussis: development and use of acellular pertussis vaccine

Zhurnal mikrobiologii, epidemiologii, i immunobiologii
R P ChuprininaN A Ozeretskovskiĭ

Abstract

Modern data substantiating the expediency of the use of acellular pertussis vaccine were analyzed. Serious postvaccinal complications caused by the action of the corpuscular pertussis component of adsorbed DPT vaccine served as the basis for the development of acellular pertussis vaccine (APV). During the period of 1990-1996 as many as 8 international field trials of the effectiveness of APV were carried out. The results of these trials and studies were evaluated in accordance with the unified programs and criteria. The vaccines under test differed by the composition of Bordetella pertussis purified antigens they contained, the methods of their purification and the detoxification of pertussis toxin. All tested APV, with the exception SKB-2, possessed pronounced prophylactic activity.

Related Concepts

Related Papers

Zhurnal mikrobiologii, epidemiologii, i immunobiologii
R P ChuprininaIu Kh Eglit
Journal of the Formosan Medical Association = Taiwan Yi Zhi
L M HuangT Kuo
© 2021 Meta ULC. All rights reserved